OptiNose (OPTN) News Today $0.37 +0.03 (+8.90%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period OptiNose (NASDAQ:OPTN) Earns Buy Rating from HC WainwrightNovember 17, 2024 | americanbankingnews.comHC Wainwright Issues Positive Estimate for OptiNose EarningsNovember 17, 2024 | americanbankingnews.comOptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price TargetNovember 16, 2024 | finance.yahoo.comFY2024 EPS Estimates for OptiNose Raised by HC WainwrightOptiNose, Inc. (NASDAQ:OPTN - Free Report) - Investment analysts at HC Wainwright raised their FY2024 EPS estimates for shares of OptiNose in a research report issued to clients and investors on Wednesday, November 13th. HC Wainwright analyst M. Caufield now forecasts that the company will earn (November 15, 2024 | marketbeat.comOptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Revised GuidanceNovember 13, 2024 | finance.yahoo.comOptinose price target lowered to $1 from $3 at Piper SandlerNovember 13, 2024 | markets.businessinsider.comOptinose (OPTN) Gets a Buy from Piper SandlerNovember 13, 2024 | markets.businessinsider.comHC Wainwright Reiterates Buy Rating for OptiNose (NASDAQ:OPTN)HC Wainwright reaffirmed a "buy" rating and set a $5.00 price objective on shares of OptiNose in a report on Wednesday.November 13, 2024 | marketbeat.comOptinose Shows Prescription Growth Amid Revenue ChallengesNovember 13, 2024 | markets.businessinsider.comOptinose, Inc.: Optinose Reports Third Quarter 2024 Financial Results and Recent Operational HighlightsNovember 12, 2024 | finanznachrichten.deOptinose reports Q3 EPS 0c, consensus (5c)November 12, 2024 | markets.businessinsider.comInsights Ahead: OptiNose's Quarterly EarningsNovember 12, 2024 | benzinga.comOptinose cuts FY24 XHANCE revenue view to $75M-$79M from $85M-$90MNovember 12, 2024 | markets.businessinsider.comOptiNose Inc (OPTN) Q3 2024 Earnings Report Preview: What To ExpectNovember 12, 2024 | finance.yahoo.comOptiNose, Inc. (OPTN) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comOptinose Reports Third Quarter 2024 Financial Results and Recent Operational HighlightsNovember 12, 2024 | globenewswire.comOptinose to Announce Q3 2024 Financial Results with Investor CallNovember 8, 2024 | msn.comOptiNose (OPTN) Scheduled to Post Quarterly Earnings on TuesdayOptiNose (NASDAQ:OPTN) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 6, 2024 | marketbeat.comOptinose Announces Reporting Date for Third Quarter 2024 Financial ResultsNovember 5, 2024 | globenewswire.comPositive week for OptiNose, Inc. (NASDAQ:OPTN) institutional investors who lost 24% over the past yearOctober 20, 2024 | finance.yahoo.comRosalind Advisors, Inc. Expands Stake in OptiNose IncOctober 18, 2024 | finance.yahoo.comOptinose Grants Stock Options to Attract New TalentOctober 18, 2024 | msn.comOptinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 16, 2024 | globenewswire.comOptiNose Inc (OPTN) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ...October 10, 2024 | finance.yahoo.comLake Street Sticks to Their Buy Rating for Optinose (OPTN)October 9, 2024 | markets.businessinsider.comOptinose Appoints Terry Kohler As CFOOctober 8, 2024 | markets.businessinsider.comOptinose Appoints Terry Kohler as Chief Financial OfficerOctober 7, 2024 | globenewswire.com2,350,010 Shares in OptiNose, Inc. (NASDAQ:OPTN) Purchased by Stonepine Capital Management LLCStonepine Capital Management LLC bought a new stake in OptiNose, Inc. (NASDAQ:OPTN - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 2,350,010 shares of the company's stock, valued at approximately $2,444,000. OptiNoseOctober 1, 2024 | marketbeat.comGreat Point Partners LLC Increases Stock Position in OptiNose, Inc. (NASDAQ:OPTN)Great Point Partners LLC grew its position in shares of OptiNose, Inc. (NASDAQ:OPTN - Free Report) by 56.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 13,727,097 shares of the company's stock after purchasing an additional 4,940,779 sSeptember 24, 2024 | marketbeat.comOptiNose (NASDAQ:OPTN) Shares Down 2.1% OptiNose (NASDAQ:OPTN) Shares Down 2.1%September 17, 2024 | marketbeat.comOptiNose (NASDAQ:OPTN) shareholders have endured a 88% loss from investing in the stock five years agoSeptember 14, 2024 | finance.yahoo.comNew Study Highlights XHANCE’s Efficacy in Treating Chronic RhinosinusitisSeptember 7, 2024 | msn.comNew Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus SurgerySeptember 5, 2024 | globenewswire.comOptinose to Present at Global Investment ConferenceAugust 27, 2024 | msn.comOptinose to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 26, 2024 | globenewswire.comOptiNose, Inc. (NASDAQ:OPTN) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | msn.comOptiNose Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 11, 2024 | finance.yahoo.comOptinose Reports Q2 2024 Financial Results and Operational HighlightsAugust 10, 2024 | msn.comOptinose Reports Second Quarter 2024 Financial Results and Recent Operational HighlightsAugust 8, 2024 | markets.businessinsider.comOptinose to Announce Q2 2024 Financial Results and Host Conference CallAugust 4, 2024 | msn.comOptiNose (OPTN) Scheduled to Post Quarterly Earnings on ThursdayOptiNose (NASDAQ:OPTN) will be releasing earnings before the market opens on Thursday, August 8, Zacks reports.August 3, 2024 | marketbeat.comOptinose Announces Reporting Date for Second Quarter 2024 Financial ResultsAugust 2, 2024 | globenewswire.comOptiNose, Inc. (NASDAQ:OPTN) Sees Large Drop in Short InterestOptiNose, Inc. (NASDAQ:OPTN - Get Free Report) was the recipient of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 5,700,000 shares, a decrease of 26.2% from the June 30th total of 7,720,000 shares. Based on an average daily trading volume, of 1,280,000 shares, the short-interest ratio is presently 4.5 days.July 27, 2024 | marketbeat.comInsider Selling: OptiNose, Inc. (NASDAQ:OPTN) Insider Sells 49,408 Shares of StockJuly 19, 2024 | insidertrades.comExpanded Access to XHANCE with Addition to National Commercial FormulariesJune 27, 2024 | globenewswire.comRamy A. Mahmoud Sells 18,987 Shares of OptiNose, Inc. (NASDAQ:OPTN) StockJune 20, 2024 | insidertrades.comOptiNose, Inc. (NASDAQ:OPTN) CEO Ramy A. Mahmoud Sells 18,987 SharesOptiNose, Inc. (NASDAQ:OPTN - Get Free Report) CEO Ramy A. Mahmoud sold 18,987 shares of the company's stock in a transaction on Tuesday, June 18th. The stock was sold at an average price of $1.19, for a total transaction of $22,594.53. Following the transaction, the chief executive officer now owns 1,318,404 shares of the company's stock, valued at $1,568,900.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.June 18, 2024 | marketbeat.comOptiNose, Inc. (NASDAQ:OPTN) Short Interest UpdateOptiNose, Inc. (NASDAQ:OPTN - Get Free Report) was the recipient of a large growth in short interest in May. As of May 15th, there was short interest totalling 7,290,000 shares, a growth of 23.1% from the April 30th total of 5,920,000 shares. Based on an average trading volume of 1,190,000 shares, the days-to-cover ratio is presently 6.1 days.June 3, 2024 | marketbeat.comMVM Partners LLC Invests $18.77 Million in OptiNose, Inc. (NASDAQ:OPTN)MVM Partners LLC acquired a new position in OptiNose, Inc. (NASDAQ:OPTN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 14,605,263 shares of the company's stock, valued at approximatelJune 1, 2024 | marketbeat.comOptiNose, Inc. (NASDAQ:OPTN) Q1 2024 Earnings Call TranscriptMay 19, 2024 | msn.com Get OptiNose News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTN and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW OPTN Media Mentions By Week OPTN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPTN News Sentiment▼0.460.46▲Average Medical News Sentiment OPTN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPTN Articles This Week▼72▲OPTN Articles Average Week Get OptiNose News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mustang Bio News Veru News Solid Biosciences News XBiotech News Acrivon Therapeutics News Corbus Pharmaceuticals News Amarin News Enanta Pharmaceuticals News Neurogene News Lexeo Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPTN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiNose, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiNose With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
